S&P Dow Jones Indices the world's leading index provider, today announced the results of the annual Dow Jones Sustainability Indices rebalancing and reconstitution. The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance criteria. The DJSI, including the Dow Jones Sustainability World Index were launched in 1999 ...

S&P Dow Jones Indices ("S&P DJI"), the world's leading index provider, today announced the results of the annual Dow Jones Sustainability Indices (DJSI) rebalancing and reconstitution. The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance (ESG) criteria.

The DJSI, including the Dow Jones Sustainability World Index (DJSI World), were launched in 1999 as the pioneering series of global sustainability benchmarks available in the market. The index family is comprised of global, regional and country benchmarks.

As a result of this year's review, the following top three largest companies based on free-float market capitalization have been added to and deleted from the DJSI World. All changes are effective on Monday, November 22, 2021 .

Additions: Alphabet Inc, Medtronic plc, Gilead Sciences Inc

Deletions: Nestlé S.A. 1 , TotalEnergies SE 2 , Humana Inc 3

The DJSI World applies a transparent, rules-based constituent selection process based on the companies' S&P Global ESG Score resulting from the annual S&P Global Corporate Sustainability Assessment (CSA). The CSA consists of a rigorous questionnaire assessing both public and non-public data submitted by participating companies. This year, more than 10,000 publicly traded companies were invited to participate in the S&P Global CSA.

The full results and list of DJSI constituents are available at https://www.spglobal.com/esg/csa/ .

For more information about the DJSI methodology, please visit: www.spglobal.com/spdji .

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit: www.spglobal.com/spdji .

S&P DJI MEDIA CONTACTS:
spdji.comms@spglobal.com

April Kabahar
Head of Communications
New York, USA
(+1) 917 796 3121
april.kabahar@spglobal.com

Asti Michou
Communications Manager, EMEA
London, UK
+ 44 7970 887863
asti.michou@spglobal.com

____________________

1 Still member of DJSI Europe

2 Still member of DJSI World Enlarged

3 Still member of DJSI World Enlarged

Cision View original content: https://www.prnewswire.com/news-releases/sp-dow-jones-indices-announces-dow-jones-sustainability-indices-2021-review-results-301423444.html

SOURCE S&P Dow Jones Indices

News Provided by PR Newswire via QuoteMedia

Janssen to Showcase Progress on Respiratory Syncytial Virus Vaccine Candidate at ESWI 2021

The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) today announced it will present data from six company-sponsored studies in support of their respiratory syncytial virus (RSV) adult vaccine candidate at the Eighth European Scientific Working Group on Influenza (ESWI) meeting . The cornerstone of Janssen's presence at ESWI will be a series of presentations detailing findings from the Phase 2b CYPRESS trial in adults at increased risk for RSV.

Keep reading... Show less

Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month

Opioid-Induced Constipation Takes the Spotlight on TikTok

Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation Initiatives Aim to Spark Greater Awareness for These Conditions

Keep reading... Show less

Knight to Present at Stifel GMP's The Future of Healthcare Conference

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, is pleased to announce that Samira Sakhia, President and Chief Executive Officer, is scheduled to present at the upcoming Stifel GMP Future of Healthcare Conference on Wednesday, December 8, 2021 at 10 am ET, that will be held virtually. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be available at www.gud-knight.com .

About Knight Therapeutics Inc.

Keep reading... Show less

IDBS Polar Insight Brings Advanced Data Analytics and Visualization to BioPharma Lifecycle Management

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform.

Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Keep reading... Show less

Medtronic receives Health Canada licence for GI Genius intelligent endoscopy module with artificial intelligence system for colonoscopy

Transformative AI System Enhances Colorectal Cancer Detection Capabilities

 Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the global leader in medical technology — announced it has received a Health Canada licence for the GI Genius™ intelligent endoscopy module. GI Genius is a computer-aided detection (CADe) system that uses artificial intelligence (AI) to highlight regions of the colon suspected to have visual characteristics consistent with different types of mucosal abnormalities.

Keep reading... Show less
Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant

Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant

Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) ("Beyond Medical" or the "Company") is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").

Keep reading... Show less

Top News

Related News